CCL26-targeted siRNA treatment of alveolar yype II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration: Implications in asthma therapy

Journal of Interferon and Cytokine Research

Volumn 29, Issue 4, 2009, Pages 227-239

  Errahali, Younes J ^a   Taka, Equar ^a   Abonyo, Barack O ^a   Heiman, Ann S ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR3; EOTAXIN 2; EOTAXIN 3; INTERLEUKIN 4; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 4; RANTES; SMALL INTERFERING RNA;

ARTICLE; ASTHMA; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; EOSINOPHIL; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL TYPE 2; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH2 CELL;

ASTHMA; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES, CC; EOSINOPHILS; EPITHELIAL CELLS; HUMANS; PULMONARY ALVEOLI; RECEPTORS, CCR3; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 64549122456     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2008.0051     Document Type: Article

References (68)

1. Abonyo B, Alexander MS, Heiman AS. 2005. Autoregulation of CCL26 synthesis and secretion in A549 cells: a possible mechanism by which alveolar epithelial cells modulate airway infl ammation. Am J Physiol Lung Cell Mol Physiol 289:L478-488.
2. Bacon K, Baggiolini M, Broxmeyer H, Horuk R, Lindley I, Mantovani A, Maysushima K, Murphy P, Nomiyama H, Oppenheim J, Rot A, Schall T, Tsang M, Thorpe R, van Damme J, Wadhwa M, Yoshie O, Zlotnik A, Zook K, IUIS/WHO subcommittee on chemokine nomenclature. 2002. Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res 22:1067-1068.
3. Badewa AP and Heiman AS. 2003. Inhibition of CCL11, CCL24, and CCL26-induced degranulation in HL-60 eosinophilic cells by specifi c inhibitors of MEK1/MEK2, p38 MAP kinase and PI 3-kinase. Immunopharm Immunotoxicol 25:145-157.
4. Badewa AP, Hudson CE, Heiman AS. 2002. Regulatory effects of eotaxin, eotaxin-2 and eotaxin-3 on eosinophil degranulation and superoxide anion generation. Exp Biol Med 227(8):645-651.
5. Banwell ME, Tolley NS, Williams TJ, and Mitchell TJ. 2002. Regulation of human eotaxin-3/CCL26 expression: modulation by cytokines and glucocorticoids. Cytokine 21:317-323.
6. Barnes PJ. 2003. Pathophysiology of asthma. Eur Respir Mon 23:84-113.
7. Beck LA, Tancowny B, Brummet ME, Asaki SY, Curry SL, Penno MB, Foster M, Bahl A, Stellato C. 2006. Functional analysis of the chemokine receptor CCR3 on airway epithelial cells. J Immunol 177:3344-3354.
8. Berkman N, Ohnona S, Chung FK, Breuer R. 2001. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. Am J Respir Cell Mol Biol 24:682-687.
9. Charo IF, Ransohoff RM. 2006. The many roles of chemokines and chemokine receptors in infl ammation. N Engl J Med 354:610-621.
10. De Fougerolles A, Vornlocher H-P, Maraganore J, Lieberman J. 2007. Interfering with disease: a progress report on siRNA-based therapeutics. Nature Rev 6:443-453.
11. Dekker RJ, Boon RA, Rondaij MG, Kragt A, Volger OL, Elderkamp YW, Meijers JCM, Voorberg J, Pannekoek H, Horrevoets JG.
12. 2006. KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Blood 107:4354-4363.
13. De Lucca CV. Recent developments in CCR3 antagonists. 2006. Curr Opin Drug Discov Devel 9 (4):516-524.
14. Dulkys Y, Schramm G, Kimmig D, Knöb S, Weyergraf A, Kapp A, Elsner J. 2001. Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fi broblasts and their distinct activation profi le on human eosinophils. J Invest Dermatol 116:498-505.
15. Elsner J, Escher SE, Forssmann U. 2004. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases. Allergy 59:1243-1258.
16. Elsner J, Dulkys Y, Gupta S, Escher SE, Forssmann WB, Kapp A, Forssmann U. 2005. Differential pattern of CCR1 internalization in human eosinophils:prolonged internalization by CCL5 in contrast to CCL3. Allergy 60(11):1386-1393.
17. Fan J, Heller NM, Gorospe M, Atasoy U, Stellato C. 2005. The role of post-transcriptional regulation in chemokine gene expression in infl ammation and allergy. Eur Respir J 26:933-947.
18. Fulkerson PC, Fischetti CA, McBride ML, Hassman LM, Hogan SP, Rothenberg ME. 2006. A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway infl ammation. Proc Natl Acad Sci 103:16418-16423.
19. Garcia G, Godot V, Humbert M. 2005. New chemokine targets for asthma therapy. Curr Allergy Asthma Rep 5:155-160.
20. Green RH, Brighting CE, Mckenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID. 2002. Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial. Lancet 360:1715-1721.
21. Grimm D, Kay MA. 2007. Therapeutic application of RNAi: is mRNA targeting fi nally ready for prime time? J Clin Invest 117:3633-3641.
22. Haley KJ, Sunday ME, Porrata Y, Kelley C, Twomey A, Shahsafaei A, Galper B, Sonna LA, Lilly CM. 2008. Ontogeny of the eotaxins in human lung. Am J Physiol Lung Cell Mol Physiol 294:L214-L224.
23. Heiman AS, Abonyo BO, Darling-Reed SF, and Alexander MS. 2005. Cytokine-stimulated human lung alveolar epithelial cells release eotaxin-2 (CCL24) and eotaxin-3 (CCL26). J Interferon Cytokine Res 25:20-29.
24. Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, Kay AB, Rothenberg ME. 2008. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 38:709-750.
25. Holgate ST. 2007. Epithelium dysfunction in asthma. J Allergy Clin Immunol 120:1233-1244.
26. Holgate ST, Body KS, Janezic A, Frew AJ, Kaplin AP, Teran LM. 1997. Release of RANTES, MIP-1α and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med 156:1377-1383.
27. Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE, Ghiran S, Gerard NP, Yu C, Orkin SH, Gerard C.
28. 2004. A critical role for eosinophils in allergic airways remodeling. Science 305:1726-1729.
29. Jacobsen EA, Taranova AG, Lee NA, Lee JJ. 2007. Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? J. Allergy Clin Immunol 119:1313-1320.
30. John AE, Thomas MS, Berlin AA, Lukacs NW. 2005. Temporal production of CCL28 corresponds to eosinophil accumulation and airway hyperreactivity in allergic airway infl ammation. Amer J Pathol 166:345-353.
31. Joubert P, Lajoie-Kadoch S, Labonte I, Gounni AS, Maghni K, Wellemans V, Chakir J, Laviolette M, Hamid Q, Lamkhioued B.
32. 2005. CCR3 expression and function in asthmatic airway smooth muscle cells. J Immunol 175:2702-2708.
33. Kikuchi I, Kikuchi S, Kobayashi T, Hagiwarar K, Sakamoto Y, Kanazawa M, Nagata M. 2006. Eosinophil trans-basement membrane migration induced by interleukin-8 and neutrophils. Am J Respir Cell Mol Biol 34:760-766.
34. Kitauri M, Suzuki N, Imai T, Takagi S, Suzuki R, Nakajima T, Hirai K, Nomiyama H, Yoshie O. 1999. Molecular cloning of a novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3. J Bio Chem 274:27975-27980.
35. Kobayashi I, Yamamoto S, Nishi N, Tsuji K, Imayosh IM, Inada S.
36. 2004. Regulatory mechanisms of Th2 cytokine-induced eotaxin-3 production in bronchial epithelial cells: possible role of interleukin 4 receptor and nuclear factor-kappaB. Ann Allergy Asthma Immunol 93:390-397.
37. Komiya A, Nagase H, Yamada H, Sekiya T, Yamaguchi M, Sano Y, Hanai N, Furuya A, Ohta K, Matsushima K, Yoshie O, Yamamoto K, and Hirai K. 2003. Concerted expression of eotaxin-1, eotaxin-2 and eotaxin-3 in human bronchial epithelial cells. Cell Immunol 225:91-100.
38. Lee JJ, Dimina D, Macias MP, Ochkur SI, McGarry MP, O'Neill KR, Protheroe C, Pero R, Nguyen T, Cormier SA, Lenkiewicz E, Colbert D, Rinaldi L, Ackerman SJ, Irvin CG, and Lee NA. 2004. Defi ning a link with asthma in mice congenitally defi cient in eosinophils. Science 305:1776-1779.
39. Loetscher P, Pellegrino A, Gong JH, Mattioli I, Loetscher M, Bardi G, Baggiolini M, Clark-Lewis I. 2001. The ligands of CXC chemokine receptor 3, I-TAC, MIG and IP-10 are natural antagonists for CCR3. J Biol Chem 276:2986-2991.
40. Moon KA, Kim SY, Kim TB, Yun ES, Park CS, Cho YS, Moon HB, Lee KY. 2007. Allergen-induced CD11b+ CD11c(int) CCR3+ macrophages in the lung promote eosinophilic airway infl ammation in a mouse asthma model. Int Immunol 19:1371-1381.
41. Morokata T, Suzuki K, Masunaga Y, Taguchi K, Morihira K, Sato I, Fujii M, Takizawa S, Toril Y, Yamamoto N, Kaneko M, Yamada T, Takahashi K, Shimizu Y. 2006. A novel, selective and orally available antagonist for CC chemokine receptor 3. J Pharamcol Exp Therap 317:244-250.
42. Murphy PM. 2002. International Union of Pharmacology. Update on chemokine receptor nomenclature. Pharmacol Rev. 54:227-229.
43. Nakamura H, Luster AD, Tateno H, Jedrzkiewicz S, Tamura G, Jaley KJ, Garcia-Zepeda EA, Yamaguchi K, and Lilly CM. 2001. IL-4 differentially regulates eotaxins and MCP-4 in lung epithelium and circulating mononuclear cells. Am J Physiol Lung Cell Mol Physiol 281:L1288-L130237.
44. Odaka M, Matsukura S, Kuga H, Kokubu F, Kasama T, Kurokawa M, Kawaguchi M, Icki K, Suzuki S, Watanabe S, Homma T, Takeuchi H, Nohtomi K, Schleimer RP, Adachi M. 2007. Differential regulation of chemokine expression by Th1 and Th2 cytokines and mechanisms of eotaxin/CCL-11 expression in human airway smooth muscle cells. Int Arch Allergy Immunol 143:84-88.
45. Ogilvie Paoletti S, Clark-Lewis I, Uguccioni M. 2003. Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes. Blood 102:789-794.
46. Opalek JM, Ali NA, Lobb JM, Hunter MG and Marsh CB. 2007. Alveolar macrophages lack CCR2 expression and do not migrate to CCL2. J Infl amm 4:19-29.
47. Pan J, Kunkel EJ, Gosslar U, Lazarus N, Langdon P, Broadwell K, Vierra MA, Genovese MC, Butcher EC, Soler D. 2000. A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J Immunol 165:2943-2949.
48. Pease JE, Williams TJ. 2006. Chemokines and their receptors in allergic disease. J Allergy Clin Immunol 118; 305-318.
49. Pechkovsky D, Goldmann T, Ludwig C, Prasse A, Vollmer E, Müller-Quernheim J, Zissel G. 2005. CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II. Respiratory Res 6:75-92.
50. Phillips RM, Stubbs VEL, Henson MR, Williams TJ, Pease JE, Sabroe I. 2003. Variations in eosinophil chemokine responses:An investigation of CCR1 and CCR3 function, expression in atopy and identifi cation of a functional CCR1 promoter. J Immunol 170:6190-6201.
51. Ponath, PD, Qin S, Post TW, Wang J, Wu L, Gerard NP, Newman W, Gerard C, Mackay CR. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 183:2437-2448.
52. Puxeddu I, Bader R, Piliponsky AM, Reich R, Levi-Schaffer F, Berkman N. 2005. The CC chemokine eotaxin/CCL11 has a selective profi brogenic effect on human lung fi broblasts. J Allergy Clin Immunol 117:103-110.
53. Ravensberg AJ, Ricciardolo FL, van Schadewijk A, Rabe KF, Sterk PJ, Hiemstra PS, Mauad T. 2005. Eotaxin-2 and eotaxin-3 expression associated with persistent eosinophilic bronchial infl ammation in patients with asthma after allergen challenge. J Allergy Clin Immunol 115:779-785.
54. Regamey N, Obregon C, Ferrari-Lacraz S, van Leer C, Chanson M, Nicod LP, Geiser T. 2007. Airway epithelial IL-15 transforms monocytes into dendritic cells. Am J Respir Cell Mol Biol 37:75-84.
55. Sanders SP. 1999. Nitric oxide in asthma. Pathogenic, therapeutic, or diagnostic? Am J Respir Cell Mol Biol 21:147-149.
56. Sanders SP, Zweier JL, Harrison SJ, Trush MA, Rembish SJ and Liu MC. 1995. Spontaneous oxygen radical production at sites of antigen challenge in allergic subjects. Am J Respir Crit Care Med 151:1725-1733.
57. Sebzda E, Zou Z, Lee JS, Wang T, Kahn ML. 2008. Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns. Nat Immunol 9(3):233-235.
58. Shinkai A, Yoshisue H, Loike M, Shoji E, Nakagawa S, Saito A, Takeda T, Imabeppu S, kato Y, Hanai N, Anazawa H, Kuga T, Nishi T. 1999. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J Immunol 163:1602-1610. Smit JJ and Lukacs. 2006. A closer look at chemokines and their role in asthmatic responses. Eur J Pharmacol 533:277-288.
59. Stellato C, Brummet ME, Plitt JR, Shahabuddin S, Baroody FM, Liu MC, Ponath PD, and Beck LA. 2001. Expression of the C-C chemokine receptor CCR3 in human airway epithelial cells. J Immunol 166:1457-61.
60. Taka E, Errahali YJ, Heiman AS. 2008. Post-transcriptional silencing of CCR3 downregulates IL-4 stimulated release of CCL26 in alveolar type II cells. FASEB J:22(4): abstract 762.4.
61. Tiffany HL, Alkhatib G, Combadiere C, Berger EA, Murhpy PM. 1998. CC chemokine receptors 1 and 3 are differentially regulated by IL-5 during maturation of eosinophilic HL-60 cells. J Immuno 160:1385-1392.
62. Wang H, Yi T, Zheng Y, He S. 2007. Induction of monocyte chemoattractant protein-1 release from A549 cells by agonists of proteaseactivated receptor-1 and -2. Eur J Cell Biol 86:233-242.
63. Witherden IR, Vanden Bon EJ, Goldstraw P, Ratcliffe C, Pastorino U, Tetley TD. 2004. Primary human alveolar type II epithelial cell chemokine release-Effects of cigarette smoke and neutrophil elastase. Am J Respir Cell Mol Biol 30:500-509.
64. Xanthou G, Duchesnes CE, Williams TJ, and Pease JE. 2003. CCR3 functional responses are regulated by both CXCR3 and it s ligands CXCL9, CXCL10 and CXCL11. Eur J Immunol 33:2241-2250.
65. Yamamoto S, Kobayashi I, Tsuji K, Nishi N, Muro E, Miyazaki M, Zaitsu M, Inada S, Ichimaru T and Hamasaki Y. 2004. Upregulation of interleukin-4 receptor by interferon-gamma: enhanced interleukin-4-induced eotaxin-3 production in airway epithelium. Am J Respir Cell Mol Biol 31:456-462.
66. Ying S, Meng Z, Zeibecoglou K, Robinson DS, Macfarlane A, Humbert M, Kay AB. 1999. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocytes chemoattractant protein-3 (MCP-3), and MCP-4, and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic asthmatics. J Immunol 163:6321-6329.
67. Yuan Q, Campanella GS, Colvin RA, Hamilos DL, Jones KJ, Mathew A, Means TK, Luster AD. 2006. Membrane-bound eotaxin-3 mediates eosinophil transepithelial migration in IL-4 stimulated epithelial cells. Eur J Immunol 36:2700-2714.
68. Zimmermann N, Hershey GK, Foster PS, Rothenberg ME. 2003. Chemokines in asthma: cooperative interactions between chemokines and IL-13. J Allergy Clin Immunol 111:227-242.